{"entity":{"type":"insider","cik":"0001709024","url":"/insider/0001709024","json_url":"/insider/0001709024.json","name":"Martin Samuel Bates","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2020-06-10","last":"2024-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Martin Samuel Bates","source":"filing","n_filings":7,"first_seen":"2020-06-10","last_seen":"2024-06-18"}],"transactions":[{"id":3177250,"accession":"0001415889-24-017363","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-017363","line_url":"/filing/0001415889-24-017363#line-3","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP AND CFO)","role_mark":"O","role_mark_label":"Officer (SVP AND CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP AND CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17172.0,"shares_display":"17,172","price_per_share":35.4248,"price_display":"35.42","price_state":"stated","total_value":608314.6656,"total_display":"608,314.67","total_whole":"608,315","shares_owned_after":28125.0,"shares_owned_after_display":"28,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-18","scope":"insider"},{"id":2222504,"accession":"0001415889-24-015147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-015147","line_url":"/filing/0001415889-24-015147#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP AND CFO)","role_mark":"O","role_mark_label":"Officer (SVP AND CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP AND CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":34.0507,"price_display":"34.05","price_state":"stated","total_value":1191774.5,"total_display":"1,191,774.50","total_whole":"1,191,775","shares_owned_after":25128.0,"shares_owned_after_display":"25,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider"},{"id":6287357,"accession":"0001415889-22-008608","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-22-008608","line_url":"/filing/0001415889-22-008608","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP AND CFO)","role_mark":"O","role_mark_label":"Officer (SVP AND CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP AND CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17547.0,"shares_display":"17,547","price_per_share":36.45230925514333,"price_display":"36.45","price_state":"stated","total_value":639628.6705,"total_display":"639,628.67","total_whole":"639,629","shares_owned_after":27664.0,"shares_owned_after_display":"27,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-12","filed_date":"2022-08-15","scope":"insider","n_lines":3},{"id":6287337,"accession":"0001415889-22-008608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-008608","line_url":"/filing/0001415889-22-008608#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP AND CFO)","role_mark":"O","role_mark_label":"Officer (SVP AND CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP AND CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2453.0,"shares_display":"2,453","price_per_share":37.0389,"price_display":"37.04","price_state":"stated","total_value":90856.4217,"total_display":"90,856.42","total_whole":"90,856","shares_owned_after":24378.0,"shares_owned_after_display":"24,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-15","scope":"insider"},{"id":4524486,"accession":"0001179110-21-011251","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-011251","line_url":"/filing/0001179110-21-011251#line-3","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":399000.0,"total_display":"399,000.00","total_whole":"399,000","shares_owned_after":24378.0,"shares_owned_after_display":"24,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-28","scope":"insider"},{"id":4255924,"accession":"0001179110-21-010208","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-21-010208","line_url":"/filing/0001179110-21-010208","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":43.566669557894734,"price_display":"43.57","price_state":"stated","total_value":413883.3608,"total_display":"413,883.36","total_whole":"413,883","shares_owned_after":28926.0,"shares_owned_after_display":"28,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider","n_lines":2},{"id":4136073,"accession":"0001179110-21-008140","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-21-008140","line_url":"/filing/0001179110-21-008140","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2738.0,"shares_display":"2,738","price_per_share":45.25,"price_display":"45.25","price_state":"stated","total_value":123894.5,"total_display":"123,894.50","total_whole":"123,895","shares_owned_after":18981.0,"shares_owned_after_display":"18,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-12","scope":"insider","n_lines":2},{"id":3013121,"accession":"0001179110-20-007166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-007166","line_url":"/filing/0001179110-20-007166#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001709024","owner_name":"Martin Samuel Bates","owner_display_name":"Martin Samuel Bates","owner_url":"/insider/0001709024","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9750.0,"shares_display":"9,750","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":29737.5,"total_display":"29,737.50","total_whole":"29,738","shares_owned_after":10735.0,"shares_owned_after_display":"10,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000744218","name":"Celldex Therapeutics, Inc.","url":"/issuer/0000744218","role":"Officer (SVP AND CFO)","n_filings":7,"first_seen":"2020-06-10","last_seen":"2024-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001709024","retrieved_at":"2026-08-25T06:47:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}